56 b) 58 c) Plan d'alerte sur les antibiotiques, pp.2011-2016 ,
61 a) Score chiffré 62 b) Classe de performance et tendance évolutive, ., p.62 ,
« Mechanisms of ?-lactam antimicrobial resistance and epidemiology of major community-and healthcare-associated multidrugresistant bacteria, Adv. Drug Deliv. Rev, 2014. ,
Régnier, et Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France, « Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program, Arch. Intern. Med, vol.170, issue.6, pp.552-559, 2010. ,
Ent??robact??ries productrices de b??ta-lactamases ?? spectre ??largi??: ??pid??miologie, facteurs de risque et mesures de pr??vention, La Revue de M??decine Interne, vol.34, issue.11, pp.687-693, 2013. ,
DOI : 10.1016/j.revmed.2012.10.365
Réseau d'alerte,d'investigation et de surveillance des infections nosocomiales (Raisin), « Surveillance des bactéries multirésistantes dans les établissements de santé français, Réseau BMR-Raisin, vol.89269, issue.2, pp.6-2015, 326905. ,
Disponible sur: http://www.scritub.com/limba, ANTIBIOTIQES- ANTIBACTERIENNES23541257.php. [Consulté le, pp.22-2015 ,
-Lactams: mode of action and mechanisms of bacterial resistance, Antibiotics in Lab-oratory Medicine, pp.502-78, 1996. ,
URL : https://hal.archives-ouvertes.fr/hal-00685796
Substrate Specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM Efflux Pumps in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.44, issue.12, pp.12-3322, 2000. ,
DOI : 10.1128/AAC.44.12.3322-3327.2000
Antibiotic Resistance Caused by Gram???Negative Multidrug Efflux Pumps, Clinical Infectious Diseases, vol.27, issue.s1, pp.32-41, 1998. ,
DOI : 10.1086/514920
Overexpression of the MtrC-MtrD-MtrE Efflux Pump Due to an mtrR Mutation Is Required for Chromosomally Mediated Penicillin Resistance in Neisseria gonorrhoeae, Journal of Bacteriology, vol.184, issue.20, pp.20-5619, 2002. ,
DOI : 10.1128/JB.184.20.5619-5624.2002
Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance., Antimicrobial Agents and Chemotherapy, vol.30, issue.1, pp.1-5, 1986. ,
DOI : 10.1128/AAC.30.1.1
Serious Infections Due to Penicillin-Resistant Strains of Viridans Streptococci with Altered Penicillin-Binding Proteins, Journal of Infectious Diseases, vol.157, issue.4, pp.764-769, 1988. ,
DOI : 10.1093/infdis/157.4.764
Penicillin???Binding Protein???Mediated Resistance in Pneumococci and Staphylococci, The Journal of Infectious Diseases, vol.179, issue.s2, pp.353-359, 1999. ,
DOI : 10.1086/513854
Molecular genetics of methicillin-resistant Staphylococcus aureus, International Journal of Medical Microbiology, vol.292, issue.2, pp.67-74, 2002. ,
DOI : 10.1078/1438-4221-00192
Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium., Antimicrobial Agents and Chemotherapy, vol.38, issue.9, pp.1980-1983, 1994. ,
DOI : 10.1128/AAC.38.9.1980
Penicillin-Binding Protein 5 Sequence Alterations in Clinical Isolates of Enterococcus faecium with Different Levels of ??-Lactam Resistance, Journal of Infectious Diseases, vol.178, issue.1, pp.159-163, 1998. ,
DOI : 10.1086/515605
Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae, Nature, vol.87, issue.5007, pp.239-241, 1965. ,
DOI : 10.1021/ac60172a054
??pid??miologie des b??ta-lactamases ?? spectre ??largi??: l???av??nement des CTX-M, Antibiotiques, vol.12, issue.1, pp.3-16, 2010. ,
DOI : 10.1016/j.antib.2010.01.003
Extended-spectrum ??-lactamase-producing Enterobacteriaceae: an emerging public-health concern, The Lancet Infectious Diseases, vol.8, issue.3, pp.159-166, 2008. ,
DOI : 10.1016/S1473-3099(08)70041-0
« The structure of beta-lactamases », Philos, Trans. R. Soc. Lond. B. Biol ,
A functional classification scheme for beta-lactamases and its correlation with molecular structure, Antimicrobial Agents and Chemotherapy, vol.39, issue.6, pp.1211-1233, 1995. ,
DOI : 10.1128/AAC.39.6.1211
Extended-Spectrum Beta-Lactamases, Seminars in Respiratory and Critical Care Medicine, vol.24, issue.1, pp.657-686, 2005. ,
DOI : 10.1055/s-2003-37919
The New ??-Lactamases, New England Journal of Medicine, vol.352, issue.4, pp.380-391, 2005. ,
DOI : 10.1056/NEJMra041359
Emergence of Enterobacteriaceae producing extended-spectrum ??-lactamases (ESBLs) in the community, Journal of Antimicrobial Chemotherapy, vol.56, issue.1, pp.52-59, 2005. ,
DOI : 10.1093/jac/dki166
Genetic support of extended-spectrum betalactamases, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.14, pp.75-81, 2008. ,
Extended-spectrum beta-lactamases., Antimicrobial Agents and Chemotherapy, vol.33, issue.8, pp.1131-1136, 1989. ,
DOI : 10.1128/AAC.33.8.1131
Antimicrobial resistance surveillance in Europe 2013 -antimicrobial- resistance-surveillance-europe-2013.pdf ». [En ligne]. Disponible sur, pp.12-2015 ,
Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge, M??decine et Maladies Infectieuses, vol.44, issue.2, pp.51-56, 2014. ,
DOI : 10.1016/j.medmal.2013.11.007
Les carbap??n??mases des ent??robact??ries, Les carbapénèmases des entérobactéries, pp.154-162, 2010. ,
DOI : 10.1016/S0929-693X(10)70918-0
« Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases, Lancet Infect. Dis, vol.13, issue.9, pp.785-796, 2013. ,
« Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study, Lancet Infect. Dis, vol.10, issue.9, pp.597-602, 2010. ,
The emerging NDM carbapenemases, The emerging NDM carbapenemases, pp.588-595, 2011. ,
DOI : 10.1016/j.tim.2011.09.005
« Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey, J. Antimicrob. Chemother, vol.61, issue.1, pp.59-63, 2008. ,
The emerging threat of acquired carbapenemases in Gram-negative bacteria, Clinical Microbiology and Infection, vol.16, issue.2, pp.99-101, 2010. ,
DOI : 10.1111/j.1469-0691.2009.03114.x
Réseau d'alerte,d'investigation et de surveillance des infections nosocomiales (Raisin), « Entérobactéries productrices de carbapénèmases, EPC ,
invs.sante.fr/Publications-et-outils/Rapports-et- syntheses/Maladies-infectieuses/2014/Consommation-d-antibiotiques-et-resistance-aux- antibiotiques-en-France-necessite-d-une-mobilisation-determinee-et-durable, Consulté le, pp.7-2015 ,
Comparative review of the carbapenems, pp.1027-1052, 2007. ,
Carbapenems: Past, Present, and Future, Antimicrobial Agents and Chemotherapy, vol.55, issue.11, pp.4943-4960, 2011. ,
DOI : 10.1128/AAC.00296-11
Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties, Journal of Antimicrobial Chemotherapy, vol.53, issue.suppl_2, pp.7-9, 2004. ,
DOI : 10.1093/jac/dkh203
Carbapenems, Journal of Chemotherapy, vol.237, issue.2, pp.1-17, 2013. ,
DOI : 10.1016/j.ijsu.2005.03.010
Comparative Pharmacokinetics of the Carbapenems, Comparative Pharmacokinetics of the Carbapenems, pp.185-201, 2012. ,
DOI : 10.2165/00003088-200039030-00002
Redefining penems, Biochemical Pharmacology, vol.71, issue.7, pp.1085-1095, 2006. ,
DOI : 10.1016/j.bcp.2005.12.003
Safety profile of meropenem: International clinical experience based on the first 3125 patients treated with meropenem, Journal of Antimicrobial Chemotherapy, vol.36, issue.suppl A, pp.207-223, 1995. ,
DOI : 10.1093/jac/36.suppl_A.207
Safe Use of Meropenem in a Patient with a Possible Nonimmediate Allergy to Imipenem, Pharmacotherapy, vol.57, issue.1, pp.1334-1338, 2007. ,
DOI : 10.1111/j.1398-9995.2004.00678.x
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections, Antimicrob. Agents Chemother, vol.51, issue.10, pp.3531-3536, 2007. ,
Extended-spectrum ??-lactamases and the permeability barrier, Clinical Microbiology and Infection, vol.14, pp.82-89, 2008. ,
DOI : 10.1111/j.1469-0691.2007.01860.x
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs, Clinical Infectious Diseases, vol.42, issue.Supplement 2 ,
DOI : 10.1086/499406
Carratalà, « Factors influencing mortality In neutropenic patients with haematological malignancies or solid tumours with bloodstream infection ,
during Oral Administration of Trimethoprim or Trimethoprim-Sulfamethoxazole, New England Journal of Medicine, vol.306, issue.3, pp.130-135, 1982. ,
DOI : 10.1056/NEJM198201213060302
Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit., Antimicrobial Agents and Chemotherapy, vol.30, issue.6, pp.945-947, 1986. ,
DOI : 10.1128/AAC.30.6.945
« Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae, JAMA, vol.279, issue.5, pp.365-370, 1998. ,
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use, JAMA, vol.289, issue.7, pp.885-888, 2003. ,
Elseviers, « Outpatient antibiotic use in Europe and association with resistance: a cross-national database study », The Lancet, pp.9459-579, 2005. ,
« Plan national d'alerte sur les antibiotiques 2011-2016 ». [En ligne]. Disponible sur, pp.7-2015 ,
The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance, N. Engl. J. Med, vol.337, issue.7, pp.441-446, 1997. ,
Bacterial Resistance: Origins, Epidemiology, and Impact, Bacterial Resistance: Origins, Epidemiology, and Impact, pp.11-23, 2003. ,
DOI : 10.1086/344654
Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria, Am. J. Respir. Crit. Care Med, vol.162, pp.837-843, 2000. ,
Consumption of Imipenem Correlates with ??-Lactam Resistance in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.46, issue.9, pp.2920-2925, 2002. ,
DOI : 10.1128/AAC.46.9.2920-2925.2002
An antibiotic policy to prevent emergence of resistant bacilli, The Lancet, vol.355, issue.9208, pp.9208-973, 2000. ,
DOI : 10.1016/S0140-6736(00)90015-1
Rapport d'évaluation du plan pour préserver l'efficacité des antibiotiques, Disponible sur, pp.22-2015, 2007. ,
Circulaire DHOS/E 2- DGS/SD5A n°2002-272 du 2 mai 2002 relative au bon usage des antibiotiques dans les établissements de santé et à la mise en place à titre expérimental de centres de conseil en antibiothérapie pour les médecins libéraux ». [En ligne]. Disponible sur, pp.22-2015 ,
Réseau d'alerte,d'investigation et de surveillance des infections nosocomiales (Raisin), « Enquête nationale de prévalence des infections nosocomiales et des traitements anti-infectieux en établissements de santé, p.2012, 2013. ,
134 du 27 mars 2012 relative au bilan des activités de lutte contre les infections nosocomiales dans les établissement de santé pour l'année 2011 et modifiant son annexe 4 ». [En ligne]. Disponible sur, 286 du 16 juillet 2012 complétant la circulaire n°DGOS/PF2, pp.22-2015, 2012. ,
COL04-05 Retour sur l???utilisation pratique de l???outil ConsoRes ??? un pl??biscite ?? 3 ans du d??but d???un d??ploiement progressif, M??decine et Maladies Infectieuses, vol.44, issue.6, p.8, 2014. ,
DOI : 10.1016/S0399-077X(14)70058-7
How to improve the collection and analysis of hospital antibiotic consumption: Preliminary results of the ConsoRes software experimental implementation, M??decine et Maladies Infectieuses, vol.42, issue.4, pp.154-160, 2012. ,
DOI : 10.1016/j.medmal.2012.02.006
François, « Apport d'une consultation systématique d'infectiologie à la maîtrise de l'antibiothérapie en réanimation, pp.281-287, 2005. ,
Am??liorer la prescription d'antibiotiques ?? l'h??pital??: comment??? Formation, organisation, ??valuation??: ??valuation et action, M??decine et Maladies Infectieuses, vol.33, pp.93-104, 2003. ,
DOI : 10.1016/S0399-077X(02)00443-2
Appropriate use of carbapenems in the Besan??on university hospital, Appropriate use of carbapenems in the Besançon university hospital, pp.510-516, 2012. ,
DOI : 10.1016/j.medmal.2012.07.004
« [Evaluation of clinical practice, medical computerized database and improvement of antibiotic therapy for acute community-acquired pneumonia] », Médecine Mal, Infect, vol.40, issue.7, pp.412-417, 2010. ,
Impact of a multidisciplinary staff meeting on the quality of antibiotherapy prescription for bone and joint infections in orthopedic surgery, Médecine Mal. Infect, vol.42, issue.12, pp.603-607, 2012. ,